The Art of Capturing Beauty at the Nanoscale




National Growth Fund invests 325 million euros in Oncode-PACT

Apr 14, 2022

The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer drugs. This has just been announced during the press conference by Jeroen Dijsselbloem, chairman of the National Growth Fund Committee.

Cleantech Company Summit Nanotech Closes US$14M Series A Round to Advance Sustainable Lithium Extraction

Mar 01, 2022

Summit Nanotech Corporation, a leader in sustainable lithium extraction, announced today the closing of a Series A investment round of US$14M, co-led by Xora Innovation (an early-stage deep tech investing platform of Temasek) and Capricorn’s Technology Impact Fund, along with BHP Ventures. Funds will be used to advance the commercialization of Summit Nanotech’s technology.

Celanese will buy DuPont’s engineering polymer and elastomer businesses for $11 billion

Feb 24, 2022

In a deal that will combine two of the world’s leading engineering polymer businesses, Celanese has agreed to acquire most of DuPont’s Mobility and Materials unit for $11 billion.

Semarion Raises £2.14 Million GBP ($2.89 Million USD) Seed Funding

Feb 22, 2022

Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, announced today that it has closed a £2.14 million GBP seed funding round.

SEK 99 million to small lead-cooled nuclear reactors

Feb 21, 2022

Researchers and industry in Sweden are working closely together to realise fourth generation lead-cooled nuclear power plants. Testing and preparatory work is in progress at KTH ahead of production of the reactors of the future.

Bristol's FluoretiQ announces the closure of £1.1 million funding round

Feb 21, 2022

University of Bristol spin-out, FluoretiQ, has today announced the completion of a £1.1 million, pre-series A investment. Their pioneering NANOPLEX technology is a 15-minute proprietary diagnostic platform for bacterial infections.

Terray Therapeutics Launches with $60M to Deliver Premium Chemical Data at Unrivaled Scale, Unlocking the Potential of AI-Driven Small Molecule Drug Discovery

Feb 15, 2022

Terray Therapeutics, a biotechnology company propelling drug discovery into the information age, today announced the closing of a $60 million Series A financing to advance its novel tNova platform and deliver therapies to patients faster than ever before.

Integrated NanoMaterials Laboratory expands resources